Sponsor:
Oregon Health and Science University
Code:
NCT06036095
Conditions
Neurocognitive Disorders
Anesthesia
Post-operative Delirium
Post-operative Cognitive Dysfunction
Eligibility Criteria
Sex: All
Age: 70+
Healthy Volunteers: Accepted
Interventions
Sevoflurane
Propofol
Brief summary:
Conditions
Neurocognitive Disorders
Anesthesia
Post-operative Delirium
Post-operative Cognitive Dysfunction
Study ID
NCT06036095
Start date
Aug 14, 2023
Status verified date
Apr, 2024
Completion date
Mar 15, 2027
Anticipated
Primary completion date
Mar 15, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 70+
Healthy Volunteers: Accepted
Enrollment
260 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
active comparator: Inhalational Anesthesia
active comparator: Intravenous Anesthesia
Interventions
Sevoflurane
Propofol
Primary outcome measure
Central contacts
Locations
Oregon Health & Science University
Recruiting
Portland, Oregon, United States, 97239
Contacts
Sarah Feller, BS
fellersa@ohsu.eduKimberly Chun, BS
chunk@ohsu.eduPrincipal Investigator:
Katie Schenning, MD
Sponsor
Oregon Health and Science University
Last update posted
Apr 8, 2024
Last verified
Apr, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Oregon Health and Science University on 2024-04-08.